 Inhibikase Therapeutics, Inc. NASDAQ:IKT Q2 2022 Earnings Conference Call August 15, 2022 8:00 AM ET CompanyParticipants Milton Werner - CEO Joseph Frattaroli - CFO Alex Lobo - Stern IR Conference Call Participants Danya Ben-Hail - JonesTrading Operator Good day, and welcome to Inhibikase Therapeutics Second Quarter 2022 Financial Results Conference Call. All participants are in listen-only mode. 